Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL29550714

NC(=O)c1ccc2c(c1)CC1(CCNCC1)C2.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.39
PDK2 Q15119 2/20 0.36
GABRD O14764 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB1 P18505 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
GABRB2 P47870 1/20 0.36
GABRA4 P48169 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.34
MAPKAPK2 P49137 1/20 0.34
NAMPT P43490 1/20 0.34
SMYD3 Q9H7B4 1/20 0.33
DPP4 P27487 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22789664 0.91 KDM1A (0.44) KDM1AGABRDGABRA1GABRB1GABRA5
SCHEMBL31657080 0.91 KDM1A (0.44) KDM1AGABRDGABRA1GABRB1GABRA5
Trifluoroacetic Acid SCHEMBL30695741 0.82 KDM1A (0.39) KDM1A
SCHEMBL30948434 0.81 ALDH1A1 (0.46) KDM1AGABRDGABRA1GABRB1GABRA5
SCHEMBL30948433 0.81 ALDH1A1 (0.46) KDM1AGABRDGABRA1GABRB1GABRA5
SCHEMBL18153851 0.76 KDM1A (0.49) KDM1AOPRM1OPRD1OPRK1SIRT2
SCHEMBL23811615 0.73 OTUD7B (0.41) KDM1APDK2GABRDGABRA1GABRB1
SCHEMBL29604529 0.73 OTUD7B (0.41) KDM1APDK2GABRDGABRA1GABRB1
SCHEMBL21084088 0.72 ALDH1A1 (0.44) KDM1ANAMPT
SCHEMBL21084148 0.72 ALDH1A1 (0.44) KDM1ANAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12209074-B2 SHP2 phosphatase allosteric inhibitor BEIJING SHENOGEN PHARMA GROUP LTD. (CN) 2025-01-28 US disclosed
US-20220388977-A1 SHP2 PHOSPHATASE ALLOSTERIC INHIBITOR BEIJING SHENOGEN PHARMA GROUP LTD. (CN) 2022-12-08 US disclosed
EP-3984999-A1 SHP2 PHOSPHATASE ALLOSTERIC INHIBITOR Beijing Shenogen Pharma Group Ltd. (CN) 2022-04-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220388977-A1 SHP2 PHOSPHATASE ALLOSTERIC INHIBITOR PTPN1, PTPN5, PTPN18 KDM1A 931/4885PDK2 1951/4885GABRD 2308/4885
US-12209074-B2 SHP2 phosphatase allosteric inhibitor PTPN1, PTPN5, PTPN18 KDM1A 931/4885PDK2 1951/4885GABRD 2308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.